P3-040: verubecestat pharmacokinetic and exposure-response results from apecs, a phase 3 trial in prodromal alzheimer's diseaseJulie A. Stone,Huub Jan Kleijn,David J. Jaworowicz,Julie Passarell,Marissa Dockendorf,Ming Xu,Christian Rasmussen,Rebecca Humphrey,Tiffini Voss,Michael F. EganAlzheimer's & Dementia(2019)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要